| Literature DB >> 20224287 |
Abstract
The efficacy of dopamine (DA) agonists in the treatment of motor symptoms of Parkinson's disease (PD) has been clearly demonstrated. It has also been documented that DA agonists may have both a positive and a negative impact on neuropsychiatric symptoms in PD patients. This paper will focus on the effects of DA agonists on depressive and cognitive symptoms of PD. Copyright 2010 S. Karger AG, Basel.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20224287 DOI： 10.1159/000295665
Source DB: PubMed Journal: Neurodegener Dis ISSN： 1660-2854 Impact factor: 2.977